inotuzumab ozogamicin(redirected from CMC-544)
inotuzumab ozogamicinA humanised CD22 linked to calicheamicin, which is being studied as a possible therapy for acute lymphoblastic leukaemia. Early data suggests that it can induce the desirable apoptosis of malignant cells at lower doses than those required for the CD33 immunotoxin gemtuzumab ozogamicin (Mylotarg) in acute myeloid leukaemia,
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.